Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.12 USD | +1.14% | -0.94% | -27.71% |
Business Summary
Number of employees: 525
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Drugs
100.0
%
| 243 | 100.0 % | 241 | 100.0 % | -1.03% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 243 | 100.0 % | 241 | 100.0 % | -1.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 07-11-30 | |
Director of Finance/CFO | 57 | 08-12-31 | |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Patrick O'brien
CMP | Compliance Officer | 60 | 14-11-30 |
Bruce Given
COO | Chief Operating Officer | 69 | 11-10-25 |
Vincent Anzalone
IRC | Investor Relations Contact | - | - |
Aaron Tan
AUD | Comptroller/Controller/Auditor | - | 21-06-30 |
Nadia Meshkova
TRE | Treasurer | - | - |
Tracie Oliver
PRN | Corporate Officer/Principal | 62 | 22-05-31 |
Matt Pulisic
PRN | Corporate Officer/Principal | - | 20-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Douglass Given
CHM | Chairman | 71 | 10-11-22 |
Michael Perry
BRD | Director/Board Member | 64 | 11-12-18 |
Adeoye Olukotun
BRD | Director/Board Member | 79 | 20-08-31 |
Hong Bo Lu
BRD | Director/Board Member | 53 | Mar. 31 |
Chief Executive Officer | 54 | 07-11-30 | |
William Waddill
BRD | Director/Board Member | 67 | 17-12-31 |
Mauro Ferrari
BRD | Director/Board Member | 64 | 10-08-18 |
Director/Board Member | 60 | 22-05-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 123,896,914 | 118,333,484 ( 95.51 %) | 0 | 95.51 % |
Company contact information
Arrowhead Pharmaceuticals, Inc.
177 East Colorado Boulevard Suite 700
91105, Pasadena
+626 304 3400
http://www.arrowheadpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.71% | 2.71B | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- ARWR Stock
- Company Arrowhead Pharmaceuticals, Inc.